|
Casanova, Jean-Laurent; Abel, Laurent (2018) Human genetics of infectious diseases: Unique insights into immunological redundancy. Semin Immunol 36:1-12
|
|
Kimble, Danielle C; Lach, Francis P; Gregg, Siobhan Q et al. (2018) A comprehensive approach to identification of pathogenic FANCA variants in Fanconi anemia patients and their families. Hum Mutat 39:237-254
|
|
Knorr, David A; Dahan, Rony; Ravetch, Jeffrey V (2018) Toxicity of an Fc-engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable antitumor immunity. Proc Natl Acad Sci U S A 115:11048-11053
|
|
Meyers, Kathrine; Rodriguez, Kristina; Brill, Atrina L et al. (2018) Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants. AIDS Behav 22:1209-1216
|
|
Knorr, David A; Ravetch, Jeffrey V (2018) Immunotherapy and Hyperprogression: Unwanted Outcomes, Unclear Mechanism. Clin Cancer Res :
|
|
Mancini, Donna; Monteagudo, Juan; Suárez-Fariñas, Mayte et al. (2018) New methodologies to accurately assess circulating active transforming growth factor-?1 levels: implications for evaluating heart failure and the impact of left ventricular assist devices. Transl Res 192:15-29
|
|
Yuferov, Vadim; Zhang, Yong; Liang, Yupu et al. (2018) Oxycodone Self-Administration Induces Alterations in Expression of Integrin, Semaphorin and Ephrin Genes in the Mouse Striatum. Front Psychiatry 9:257
|
|
Lu, Ching-Lan; Pai, Joy A; Nogueira, Lilian et al. (2018) Relationship between intact HIV-1 proviruses in circulating CD4+ T cells and rebound viruses emerging during treatment interruption. Proc Natl Acad Sci U S A 115:E11341-E11348
|
|
Asur, Rajalakshmi S; Kimble, Danielle C; Lach, Francis P et al. (2018) Somatic mosaicism of an intragenic FANCB duplication in both fibroblast and peripheral blood cells observed in a Fanconi anemia patient leads to milder phenotype. Mol Genet Genomic Med 6:77-91
|
|
Reed, Brian; Butelman, Eduardo R; Fry, Rebecca S et al. (2018) Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence. Neuropsychopharmacology 43:739-750
|
Showing the most recent 10 out of 66 publications
